23 March 2011
Left ventricular assist device as ‘bridge to weight loss’ prior to transplantation in obese patients with advanced heart failure
Pavittarpaul DhesiABCDEF, Sinan A. SimsirAE, Daniel DaneshvarBC, Asim RafiqueBC, Anita PhanADEF, Ernst R. SchwarzADEFAnn Transplant 2011; 16(1): 5-13 :: ID: 881632
Abstract
Background: Obesity is a risk factor for heart failure (HF) and associated with poor outcomes after cardiac transplantation.
We assessed change in total body weight, morbidity and mortality in obese heart failure patients after implantation of a left ventricular assist device (LVAD) compared to medical management.
Material/Methods: Nineteen patients (9 females, age 51.3±10 years) with a body mass index (BMI) ≥30.0 kg/m2 and advanced HF (NYHA class III–IV, stage D) were evaluated. Thirteen (group 1) received insertion of a LVAD as bridge to transplantation. The remaining patients (group 2) were medically managed. All were advised on lifestyle modification.
Results: At baseline, group 1 (49.1±10.7 years) had a total body weight (BW) of 246.6±34.9 pounds (mean ±SD) and a BMI of 36.1±4 kg/m2. Group 2 (56±6.7 yrs) had a BW of 238.8±73.6 pounds and a BMI of 39.1±9.3 kg/m2 (n.s. compared to group 1). All patients were alive at 12 months. At 6 months, BW in group 1 was reduced to 216.3±20.8 pounds, and BMI to 31.8±3.3 kg/m2 (p<0.05). At 6 months, BW in group 2 was 238.2±84.6 pounds, and BMI was 39.1±11.6 kg/m2 (n.s. vs. baseline, p<0.05 compared to group 1). The decrease in BW in group 1 was 12.3±12% (30.3±28.5 pounds). There was no change in BW in group 2 (0.3±8.7%, 0.6±21 pounds, p<0.05 vs. group 1). At 12 months, 7 patients in group 1 (54%) underwent cardiac transplantation.
Conclusions: LVAD insertion resulted in weight loss in obese patients not considered for heart transplantation compared to medically managed patients.
Keywords: left ventricular assist device, obesity, Weight Loss, cardiac transplantation
In Press
Original article
Steroid Use in ABO-Incompatible Kidney Transplants: Withdrawal vs MaintenanceAnn Transplant In Press; DOI: 10.12659/AOT.947747
Original article
Intra-Arterial Contrast-Enhanced Ultrasound for Transcatheter Thrombolysis in Post-Transplant Hepatic Arter...Ann Transplant In Press; DOI: 10.12659/AOT.947500
Original article
Early Atropine Protocol Enhances Dobutamine Stress Echocardiography in End-Stage Liver Disease: A Practical...Ann Transplant In Press; DOI: 10.12659/AOT.950166
Most Viewed Current Articles
15 Aug 2023 : Review article 7,359
Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ TransplantationDOI :10.12659/AOT.939750
Ann Transplant 2023; 28:e939750
03 Jan 2023 : Original article 7,231
Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and...DOI :10.12659/AOT.938467
Ann Transplant 2023; 28:e938467
16 May 2023 : Original article 7,058
Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections ...DOI :10.12659/AOT.939258
Ann Transplant 2023; 28:e939258
28 May 2024 : Original article 6,664
Effect of Dexmedetomidine Combined with Remifentanil on Emergence Agitation During Awakening from Sevoflura...DOI :10.12659/AOT.943281
Ann Transplant 2024; 29:e943281